Comparative Effectiveness of a Second-Line Biologic in Patients with Ulcerative Colitis: Vedolizumab Followed by an Anti-Tnf Versus Anti-Tnf Followed by Vedolizumab Charles Miller , Hanson Kwok , Paul Harrow , Roser Vega , Edward Seward , Shameer Mehta , Farooq Rahman , Sara McCartney , Ioanna Parisi , Samuel Hsiang Lim , Esha Sharma , Mark A. Samaan , Aaron Bancil , Klaartje Bel Kok , Ahmed Shalabi , Emma L. Johnston , Dev Katarey , Nina Taherzadeh , Charles Murray , Mohammed Tauseef Sharip , Martyn J. Carter , Shiva T. Radhakrishnan , Simon Peake , Imran Khakoo , Mahmood Wahed , Sebastian Povlsen , Mehul Patel , Patrick DuBois , Jemima Finkel , Clive Onnie , Stuart Bloom Frontline Gastroenterology（2022）
AI 理解论文
溯源树
样例
